Sun Pharma says Halol unit listed under US FDA import alert, shares slip nearly 3%1 min read . Updated: 08 Dec 2022, 11:32 AM IST
- The import alert means all future shipments of products made at the Halol plant can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards, Sun Pharma said in a statement
The US Food and Drug Administration (FDA) had listed Sun Pharmaceutical Industries Ltd's Halol facility in Gujarat under an import alert, the company said today. Shares of Sun Pharmaceutical Industries slipped nearly 3 per cent to ₹987.15 on the BSE at 11.30 am today.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more